Integration of Ultrasound in Image-Guided Adaptive Brachytherapy in Cancer of the Uterine Cervix

• Published in: Bioengineering (Basel) Vol. 11; no. 5; p. 506
• Main Authors: Manea, Elena, Chitoran, Elena, Rotaru, Vlad, Ionescu, Sinziana, Luca, Dan, Cirimbei, Ciprian, Alecu, Mihnea, Capsa, Cristina, Gafton, Bogdan, Prutianu, Iulian, Serban, Dragos, Simion, Laurentiu
• Format: Journal Article
• Language: English
• Published: Switzerland MDPI AG 01.05.2024
• Subjects: Analysis; Anesthesia; Brachytherapy; Cancer; Cancer therapies; Care and treatment; Cervical cancer; Cervix; Chemotherapy; Computed tomography; CT imaging; Developing countries; Diagnosis; Human papillomavirus; LDCs; Magnetic resonance imaging; Medical imaging; Medical screening; oncology; Patient outcomes; Public health; Radiation therapy; Radioisotope brachytherapy; Risk factors; surgical oncology; Ultrasonic imaging; Ultrasound; Ultrasound imaging; Uterine cancer; Uterus; Vaccines; Womens health; Working groups; Romania; United States > US; cancer treatment; radiotherapy; gynaecology; cancer; brachytherapy; image guided adaptive brachytherapy; cervical cancer; oncology; ultrasound; surgical oncology
• ISSN: 2306-5354; 2306-5354
• DOI: 10.3390/bioengineering11050506

Cervical cancer continues to be a public health concern, as it remains the second most common cancer despite screening programs. It is the third most common cause of cancer-related death for women, and the majority of cases happen in developing nations. The standard treatment for locally advanced cervical cancer involves the use of external beam radiation therapy, along with concurrent chemotherapy, followed by an image-guided adaptive brachytherapy (IGABT) boost. The five-year relative survival rate for European women diagnosed with cervical cancer was 62% between 2000 and 2007. Updated cervical cancer treatment guidelines based on IGABT have been developed by the Gynecological working group, which is composed of the Group Européen de Curiethérapie-European Society for Therapeutic Radiology and Oncology. The therapeutic strategy makes use of three-dimensional imaging, which can be tailored to the target volume and at-risk organs through the use of computed tomography or magnetic resonance imaging. Under anaesthesia, the brachytherapy implantation is carried out. Ultrasonography is utilised to assess the depth of the uterine cavity and to facilitate the dilation of the uterine canal during the application insertion. In this study, we examine data from the international literature regarding the application of ultrasound in cervical cancer brachytherapy.